A Case of Corneal Thinning During S-1 Oral Administration
Ayaka Shimada, Mizuki Iida, Kana Murakami, Sho Ichioka, Akiko Harano, Masaki Tanito
TL;DR
A 69-year-old man developed corneal thinning while taking the cancer drug S-1, which improved after stopping the medication.
Contribution
Reports a new potential ocular side effect of S-1: corneal thinning.
Findings
Bilateral corneal thinning exceeding 100 µm occurred during S-1 treatment.
Visual acuity and corneal thickness returned to normal after discontinuing S-1.
Corneal thinning is a previously unreported side effect of S-1.
Abstract
We experienced a case of bilateral corneal thinning during the oral taking of S-1, a combination anti-cancer drug of tegafur, gimeracil, and oteracil-potassium. A 69-year-old man was prescribed oral S-1 for the treatment of duodenal papilla adenocarcinoma and intraductal papillary mucinous neoplasm. However, he developed a decrease in visual acuity in both eyes after three cycles of S-1 oral taking, and ophthalmic examination revealed corneal thinning exceeding 100 µm and an increase in high-order irregularity of cornea in both eyes. After one month after discontinuation of S-1, his visual acuity and corneal thickness returned to its previous levels. Besides corneal ulcers and perforations, corneal thinning can be recognized as a potential corneal side effect necessitating monitoring during S-1 treatment.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOcular Infections and Treatments · Ocular Oncology and Treatments · Cholangiocarcinoma and Gallbladder Cancer Studies